Abiopharma

🔍 ROTHBLATT MARTINE A (Executive)

Company: UNITED THERAPEUTICS Corp (UTHR)

Report Date: 2026-06-18

Detailed Transactions and Holdings:

• Acquired 9,500 shares of Common Stock at $146.03 per share (Direct)
  Date: 2026-06-18 | Code: M | equity_swap_involved: false | shares_owned_after: 50,013.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 480 shares of Common Stock at $533.7867 per share (Direct)
  Date: 2026-06-18 | Code: S | equity_swap_involved: false | shares_owned_after: 49,533.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 80 shares of Common Stock at $535.01 per share (Direct)
  Date: 2026-06-18 | Code: S | equity_swap_involved: false | shares_owned_after: 49,453.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 245 shares of Common Stock at $536.5922 per share (Direct)
  Date: 2026-06-18 | Code: S | equity_swap_involved: false | shares_owned_after: 49,208.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 828 shares of Common Stock at $537.5223 per share (Direct)
  Date: 2026-06-18 | Code: S | equity_swap_involved: false | shares_owned_after: 48,380.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 1,399 shares of Common Stock at $538.5921 per share (Direct)
  Date: 2026-06-18 | Code: S | equity_swap_involved: false | shares_owned_after: 46,981.00 | transaction_form_type: 4 | Footnotes: F1, F6
• Sold 2,793 shares of Common Stock at $539.6173 per share (Direct)
  Date: 2026-06-18 | Code: S | equity_swap_involved: false | shares_owned_after: 44,188.00 | transaction_form_type: 4 | Footnotes: F1, F7
• Sold 2,022 shares of Common Stock at $540.5195 per share (Direct)
  Date: 2026-06-18 | Code: S | equity_swap_involved: false | shares_owned_after: 42,166.00 | transaction_form_type: 4 | Footnotes: F1, F8
• Sold 613 shares of Common Stock at $541.4933 per share (Direct)
  Date: 2026-06-18 | Code: S | equity_swap_involved: false | shares_owned_after: 41,553.00 | transaction_form_type: 4 | Footnotes: F1, F9
• Sold 40 shares of Common Stock at $544.01 per share (Direct)
  Date: 2026-06-18 | Code: S | equity_swap_involved: false | shares_owned_after: 41,513.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 40 shares of Common Stock at $545.19 per share (Direct)
  Date: 2026-06-18 | Code: S | equity_swap_involved: false | shares_owned_after: 41,473.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 320 shares of Common Stock at $547.5099 per share (Direct)
  Date: 2026-06-18 | Code: S | equity_swap_involved: false | shares_owned_after: 41,153.00 | transaction_form_type: 4 | Footnotes: F1, F10
• Sold 480 shares of Common Stock at $548.8442 per share (Direct)
  Date: 2026-06-18 | Code: S | equity_swap_involved: false | shares_owned_after: 40,673.00 | transaction_form_type: 4 | Footnotes: F1, F11
• Sold 160 shares of Common Stock at $552.72 per share (Direct)
  Date: 2026-06-18 | Code: S | equity_swap_involved: false | shares_owned_after: 40,513.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-18 | Code: H | nature_of_ownership: by Spouse | shares_owned_after: 166.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-18 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 324,443.00 | Footnotes: F12
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-18 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 249,108.00 | Footnotes: F13
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-18 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 45,596.00 | Footnotes: F14
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-18 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 8,902.00 | Footnotes: F15
• Sold 9,500 shares of Stock Option at $146.03 per share (Derivative)
  Date: 2026-06-18 | Code: M | Expires: 2027-03-15 | Exercise: 2020-03-15 | equity_swap_involved: false | shares_owned_after: 2,910.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.
• F10: This transaction was executed in multiple trades at prices ranging from $546.98 to $547.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F11: This transaction was executed in multiple trades at prices ranging from $548.64 to $548.94. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F12: Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
• F13: Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
• F14: Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
• F15: Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
• F2: This transaction was executed in multiple trades at prices ranging from $533.64 to $534.42. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F3: This transaction was executed in multiple trades at prices ranging from $534.70 to $535.32. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F4: This transaction was executed in multiple trades at prices ranging from $536.00 to $536.96. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F5: This transaction was executed in multiple trades at prices ranging from $537.11 to $538.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F6: This transaction was executed in multiple trades at prices ranging from $538.11 to $539.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F7: This transaction was executed in multiple trades at prices ranging from $539.11 to $540.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F8: This transaction was executed in multiple trades at prices ranging from $540.11 to $541.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F9: This transaction was executed in multiple trades at prices ranging from $541.12 to $541.98. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.